HIV Fusion Inhibitors
- Vaccines and Antiviral AgentsEnfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition
- Vaccines and Antiviral AgentsA Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity
- Vaccines and Antiviral AgentsCreating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors
- Vaccines and Antiviral AgentsDesign of a Potent d-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance
- Vaccines and Antiviral Agents | SpotlightIdentification of a gp41 Core-Binding Molecule with Homologous Sequence of Human TNNI3K-Like Protein as a Novel Human Immunodeficiency Virus Type 1 Entry Inhibitor